Skip to main content
. 2018 Aug 22;63(12):3487–3497. doi: 10.1007/s10620-018-5251-9

Fig. 1.

Fig. 1

Effect of TDF and PEG-IFN as combination or monotherapy on HBsAg loss. The rate of HBsAg loss in group A was significantly higher than rates in group C (P < 0.001) or group D (P = 0.002). The rate of HBsAg loss in group B did not significantly differ from that in group C or group D